Literature DB >> 3909169

Motivational effects of opioids: evidence on the role of endorphins in mediating reward or aversion.

I P Stolerman.   

Abstract

It has been suggested that endogenous peptides with opiate-like effects may contribute to the mediation of reward or aversion. One line of evidence relating to these hypotheses derives from studies of the motivational effects of opioids. The ability of opioid agonists and antagonists to serve as positively reinforcing or aversive stimuli is reviewed, with results compared across several different behavioural procedures. The results for rewarding effects are consistent and independent of procedure: in self-administration, conditioned place preference and conditioned taste preference studies, opioid agonists are consistently effective whereas antagonists are inactive. Results for indices of aversive effects are more difficult to interpret because they are, to some extent, dependent on the procedure used. Neither agonists nor antagonists seem able to support operant escape/avoidance conditioning. Agonists can support taste aversion and place aversion conditioning to some extent, whereas antagonists are clearly active in both procedures. The results provide some support for the involvement of enkephalins or endorphins in reward and aversion, but there are significant gaps and contradictions in the evidence.

Mesh:

Substances:

Year:  1985        PMID: 3909169     DOI: 10.1016/0091-3057(85)90086-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization.

Authors:  Steven M Graves; Amanda L Persons; Jennifer L Riddle; T Celeste Napier
Journal:  Brain Res       Date:  2012-07-20       Impact factor: 3.252

2.  Tolerance and selective cross-tolerance to the motivational effects of opioids.

Authors:  T S Shippenberg; M W Emmett-Oglesby; F J Ayesta; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

4.  Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability.

Authors:  Claudia J Woloshchuk; Katharine H Nelson; Kenner C Rice; Anthony L Riley
Journal:  Drug Alcohol Depend       Date:  2016-08-07       Impact factor: 4.492

Review 6.  Behavioral, Neural, and Molecular Mechanisms of Conditioned Mate Preference: The Role of Opioids and First Experiences of Sexual Reward.

Authors:  Gonzalo R Quintana; Conall E Mac Cionnaith; James G Pfaus
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.